SIP
Stoneridge Investment Partners Portfolio holdings
AUM
$133M
This Quarter Return
+7.31%
1 Year Return
+2.03%
3 Year Return
+31.4%
5 Year Return
+48.11%
10 Year Return
+34.09%
AUM
$217M
AUM Growth
+$217M
(+8.3%)
Cap. Flow
+$3.2M
Cap. Flow
% of AUM
1.47%
Top 10 Holdings %
Top 10 Hldgs %
36.04%
Holding
132
New
21
Increased
23
Reduced
23
Closed
21
Top Buys
| 1 |
Baxter International
BAX
|
$3.13M |
| 2 |
Lam Research
LRCX
|
$2.76M |
| 3 |
Citigroup
C
|
$2.61M |
| 4 |
Bristol-Myers Squibb
BMY
|
$2.25M |
| 5 |
Allstate
ALL
|
$2.05M |
Top Sells
| 1 |
Merck
MRK
|
$5.14M |
| 2 |
Starbucks
SBUX
|
$2.61M |
| 3 |
W.R. Berkley
WRB
|
$2.32M |
| 4 |
Hershey
HSY
|
$2.29M |
| 5 |
Digital Realty Trust
DLR
|
$2.04M |
Sector Composition
| 1 | Technology | 29.19% |
| 2 | Communication Services | 12.29% |
| 3 | Financials | 11.61% |
| 4 | Healthcare | 11.04% |
| 5 | Consumer Discretionary | 10.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
JPMorgan Chase
JPM
$829B
| $259K | 0.12% | 1,637 | – | – |
|
102
Quanta Services
PWR
$56.3B
| $251K | 0.12% | 2,192 | – | – |
|
103
Vertex Pharmaceuticals
VRTX
$100B
| $250K | 0.12% | 1,138 -2,600 | -70% | -$571K |
|
104
Skyworks Solutions
SWKS
$11.1B
| $240K | 0.11% | 1,550 -1,400 | -47% | -$217K |
|
105
FedEx
FDX
$54.5B
| $232K | 0.11% | +897 | New | +$232K |
|
106
AT&T
T
$209B
| $220K | 0.1% | 8,950 -25,450 | -74% | -$626K |
|
107
Coterra Energy
CTRA
$18.7B
| $205K | 0.09% | 10,801 | – | – |
|
108
Target Hospitality
TH
$905M
| $37K | 0.02% | +10,400 | New | +$37K |
|
109
DURECT Corp
DRRX
$59.6M
| $17K | 0.01% | 17,719 | – | – |
|
110
TherapeuticsMD
TXMD
$12.8M
| $13K | 0.01% | 37,544 | – | – |
|
|
BXRX
111
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
| $3K | ﹤0.01% | 15,000 | – | – |
|
112
Wells Fargo
WFC
$263B
| – | – | -11,841 | Closed | -$550K |
|
113
Willis Towers Watson
WTW
$31.9B
| – | – | -2,165 | Closed | -$503K |
|
|
PAE
114
DELISTED
PAE Incorporated Class A Common Stock
PAE
| – | – | -11,925 | Closed | -$71K |
|
115
Accenture
ACN
$162B
| – | – | -3,200 | Closed | -$1.02M |
|
116
BioMarin Pharmaceuticals
BMRN
$11.2B
| – | – | -4,241 | Closed | -$328K |
|
117
Crown Castle
CCI
$43.2B
| – | – | -1,400 | Closed | -$243K |
|
118
Dollar General
DG
$23.9B
| – | – | -9,410 | Closed | -$2M |
|
119
Dollar Tree
DLTR
$22.8B
| – | – | -5,356 | Closed | -$513K |
|
120
Everest Group
EG
$14.3B
| – | – | -1,981 | Closed | -$497K |
|
121
Entergy
ETR
$39.3B
| – | – | -7,963 | Closed | -$791K |
|
122
Levi Strauss
LEVI
$8.85B
| – | – | -34,150 | Closed | -$837K |
|
123
Eli Lilly
LLY
$657B
| – | – | -5,450 | Closed | -$1.26M |
|
124
Masco
MAS
$15.4B
| – | – | -29,635 | Closed | -$1.65M |
|
|
125
Merck
MRK
$210B
| – | – | -68,406 | Closed | -$5.14M |
|